14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
BUD vs SAM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
BUD Overall Winner
6-Pillar Tally: BUD 4 – 2 SAM
Matrix Metrics: BUD 9 – 1 SAM
As of Nov 16, 2026, Anheuser-Busch INBEV SA/NV (BUD) is the stronger overall head-to-head candidate over Boston Beer Company (SAM) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BUD carries a Unified Composite Score of 34.9/100 (SELL) at $84.55 (17.4x Forward P/E, 26.7% operating margin), whereas SAM carries 38.3/100 (SELL) at $223.71 (21.5x Forward P/E, 5.6% operating margin).
Composite vs. Pillar Nuance: While SAM currently prints a higher short-term Unified Composite Score (38.3/100 SELL vs. BUD 34.9/100 SELL), BUD captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (26.7% vs. 5.6% operating margin) and revenue trajectory (+9.1% vs. -3.2% YoY).
Defensive Composite Rating Caution: Although BUD compares more favorably head-to-head, both BUD (34.9/100 SELL) and SAM (38.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BUD vs SAM. Trailing 12-month operating profitability (BUD 26.7% vs SAM 5.6%) and valuation multiples (BUD 17.4x vs SAM 21.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Beverages - Brewers value chain with $167.3B market capitalization and 26.7% operating margin.
OpEx & R&D Reinvestment29.8% of Rev ($19.1B)
90D Engineering Disclosures0 Published
SAM Moat ProfileCyclical / Execution-Driven Positioning
Beverages - Brewers Operator
Competes within the Beverages - Brewers value chain with $2.2B market capitalization and 5.6% operating margin.
OpEx & R&D Reinvestment43.5% of Rev ($830M)
90D Engineering Disclosures0 Published
Investor FAQ BUD vs SAM Key Questions & Quantitative Answers
As of Nov 16, 2026, Anheuser-Busch INBEV SA/NV (BUD) is the stronger overall head-to-head candidate over Boston Beer Company (SAM) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BUD carries a Unified Composite Score of 34.9/100 (SELL) at $84.55 (17.4x Forward P/E, 26.7% operating margin), whereas SAM carries 38.3/100 (SELL) at $223.71 (21.5x Forward P/E, 5.6% operating margin). Composite vs. Pillar Nuance: While SAM currently prints a higher short-term Unified Composite Score (38.3/100 SELL vs. BUD 34.9/100 SELL), BUD captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (26.7% vs. 5.6% operating margin) and revenue trajectory (+9.1% vs. -3.2% YoY). Defensive Composite Rating Caution: Although BUD compares more favorably head-to-head, both BUD (34.9/100 SELL) and SAM (38.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
BUD leads the Growth & Scale pillar: BUD posts +9.1% YoY revenue growth and +52.5% YoY earnings growth on $64.0B TTM revenue (56.5% gross margin, 26.7% operating margin), compared with SAM at -3.2% YoY revenue growth and -1.0% YoY earnings growth on $1.91B TTM revenue (49.1% gross margin, 5.6% operating margin). On trailing 12-month operating scale, BUD generates $64.0B in USD-normalized revenue versus $1.91B for SAM. In operating R&D and SG&A reinvestment, BUD deploys 29.8% of Rev ($19.1B) (0 90-day corporate R&D disclosures) versus 43.5% of Rev ($830M) (0 disclosures) for SAM.
BUD screens cheaper on headline valuation multiples. BUD trades at 17.4x Forward P/E, 17.3x Trailing P/E, 1.74x PEG, and 2.6x EV/Revenue (31.7% EBITDA margin), whereas SAM trades at 21.5x Forward P/E, 20.4x Trailing P/E, 0.71x PEG, and 1.0x EV/Revenue (9.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BUD (11.4% ROE) versus SAM (-8.9% ROE) capital efficiency.
In options market volatility and institutional positioning, BUD carries 23.6% implied volatility (42nd %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.23β · 33% Vol realized risk). By comparison, SAM carries 31.4% implied volatility (5th %ile, Compressed (<25th %ile)), a 0.07x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (-0.31β · 51% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.